BSEAGM/EGM3d ago · 21 Sept 2026, 10:06 pm

Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 for the proceedings of 41st Annual General Meeting of the Company held through VC mode.

Arvaya Healthcare Ltd · 524723

✦ AI SummaryResults

Arvaya Healthcare Ltd held its 41st Annual General Meeting (AGM) on September 21, 2026, through video conferencing. The meeting approved the audited financial statements for FY 2025-26, re-appointed Kaushal Shah as Managing Director, and approved a material related party transaction for the acquisition of DEFIB Institute of Health Solutions LLP's copyright and intellectual property portfolio.

Analysis Scores

Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk3/10
Balance Sheet Risk4/10
Liquidity Impact7/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Arvaya Healthcare Ltd - 524723 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Attachments (1)

📄

82e1ac90-f9be-4868-b9c4-fd23a5668eaa.pdf

pdf

Download →
View document text
Date:21st September 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street Mumbai – 400001 Respected Authorities, Sub: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”) - Proceedings of the 41st Annual General Meeting of the Company Ref: “Arvaya Healthcare Limited” (ARVAYA / 524723) We wish to inform you that the 41st Annual General Meeting (‘AGM’) of the Members of the Company was held today, i.e. Monday, 21 September, 2026 through Video Conferencing in compliance with the relevant circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Pursuant to Regulation 30 of SEBI Listing Regulations, a summary of the proceedings of the AGM is enclosed. The AGM commenced at 3:02 P.M. and concluded at 3:31 P.M. This is for your information and records. Thanking you, For ARVAYA HEALTHCARE LIMITED (formerly known as Bijoy Hans Limited) KAUSHAL SHAH MANAGING DIRECTOR DIN:02175130 Date:21st September 2026 Place: Sangli SUMMARY OF PROCEEDINGS OF THE 41ST ANNUAL GENERAL MEETING OF ARVAYA HEALTHCARE LIMITED (FORMERLY KNOWN AS BIJOY HANS LIMITED) HELD ON 21 SEPTEMBER 2026 The 41st Annual General Meeting (‘AGM’) of the Members was held today i.e. Monday, 21 September 2026 at 3:02 P.M. through Video Conferencing. CS Guinea Agrawal, welcomed all the shareholders to the meeting and then introduced the Board Members and Senior Management Officials who participated in the meeting and informed the members about the representatives of Statutory Auditors, Secretarial Auditors and Scrutinizers attending the meeting. CS Guinea Agrawal then informed that: • With the consent of the members, the Notice dated 12 August 2026 convening the AGM and the Auditors’ Report for the financial year ended 31 March 2026, were taken as read. • Remote e-voting had commenced on Friday, 18 September 2026 from 9:00 A.M. to Sunday, 20 September 2026 upto 5:00 P.M. Members who were present at the AGM and who had not cast their votes earlier during the remote e-voting period were provided an opportunity to cast their votes at the AGM. • Mr. Chinmay Mohan Lele, Practicing Company Secretary, was appointed as the Scrutinizer to scrutinize the remote e-voting process and e-voting at the AGM. She mentioned that the quorum was present and requested Mr. Kaushal Shah, Chairman and managing director of the Board of the company to preside over the meeting. The Chairman addressed the shareholders at the 41st Annual General Meeting of Arvaya Healthcare Limited, summarizing the key operational highlights and strategic direction for FY 2025–26: • Strategic Re-branding: The Company officially transitioned to Arvaya Healthcare Limited, reflecting its broader vision and expanded focus in the healthcare sector. • Business & IP Expansion: The Company continued to pursue growth opportunities across healthcare services and intellectual property initiatives to strengthen its market presence. • Governance & Financial Discipline: Strong emphasis was placed on maintaining sound corporate governance, regulatory compliance, internal controls, and financial discipline. • Long-Term Outlook: The Company reaffirmed its commitment to building a sustainable healthcare business and driving long-term stakeholder value. • Business Expansion & Corporate Updates: ➢ Incorporation of Wholly Owned Subsidiary: The Company has incorporated Arvaya Insurance Broking Private Limited as its Wholly-Owned Subsidiary as on 17th September 2026 to diversify business operations and enhance overall stakeholder value. ➢ Strategic Acquisition: The Company is currently in the process of acquiring Sushoda Institute of Gastroenterology Private Limited to expand its footprint and service capabilities within the healthcare sector. ➢ Capital Raising via Rights Issue: To support these growth initiatives and strengthen balance sheet capacity, the Company is undertaking a Rights Issue of equity shares. The chairman mentioned the points and reservation in Secretarial Audit Report were addressed by the management and he also expressed gratitude to shareholders, business partners, medical professionals, and employees for their ongoing support and contribution to the Company’s growth. The following items of business as laid down in the Notice of the AGM dated 12TH August 2026 were transacted at the AGM: Item Business Resolution Type No. (Ordinary/Special) ORDINARY BUSINESS: 1 To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the financial year Ordinary ended 31 March 2026, and the reports of the Board of Directors and Auditors thereon. 2 To receive, consider and adopt the Audited Consolidated Ordinary Financial Statements of the Company for the financial year ended 31 March 2026, and the reports of the Auditors thereon. 3 To consider appointment of Mr. Kaushal Uttam Shah (DIN: Ordinary 02175130) Managing Director of the company, who retires by rotation and, being eligible, offers himself for re-appointment. SPECIAL BUSINESS: 4 Approval for Material Related Party Transaction(s) under Ordinary Section 188 of The Companies Act, 2013 and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements), 2015. 5 To consider and approve the Material Related Party Ordinary Transaction for acquisition and assignment of the Copyright and Intellectual Property portfolio of DEFIB Institute of Health Solutions LLP, out of Rights Issue proceeds. CS Guinea Agrawal then announced that the consolidated e-voting results (remote e-voting and e- voting at the AGM) along with the consolidated scrutinizer's report shall be informed to the Stock Exchanges and also be available on the website of the Company and National Securities Depository Limited. Thereafter, Mr. Abhiram Ranganath Chief Financial Officer (CFO) of the company thanked the Members for their continued support and for attending and participating in the Meeting. The e-voting facility was kept open for the next 15 minutes to enable the shareholders to cast their vote and thereafter the AGM concluded at 3.31 p.m. **********************